2021
DOI: 10.3390/ijms22179587
|View full text |Cite
|
Sign up to set email alerts
|

Cancer-Nano-Interaction: From Cellular Uptake to Mechanobiological Responses

Abstract: With the advancement of nanotechnology, the nano-bio-interaction field has emerged. It is essential to enhance our understanding of nano-bio-interaction in different aspects to design nanomedicines and improve their efficacy for therapeutic and diagnostic applications. Many researchers have extensively studied the toxicological responses of cancer cells to nano-bio-interaction, while their mechanobiological responses have been less investigated. The mechanobiological properties of cells such as elasticity and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 179 publications
(244 reference statements)
0
11
0
Order By: Relevance
“…Under this circumstance, researchers around the world have explored a variety of new nanocarriers and targeted modification systems to overcome these shortcomings and improve the therapeutic outcomes ( Ghaz-Jahanian et al, 2015 ; Bai et al, 2021 ; Shakeran et al, 2021 ; Dubey et al, 2022 ). Because nanotechnology provides a suitable means for the targeted and time-controlled delivery of drugs and other bioactive agents, it has been widely studied in drug delivery and has potential application prospects in cancer treatment ( Sabra et al, 2017 ; George et al, 2019 ; Ion et al, 2021 ; Maspes et al, 2021 ; Sohrabi and Packirisamy, 2021 ; Li et al, 2022 ). Drug delivery systems (DDSs) refer to the methods of delivering drugs to the targeted tissues, organs, cells or subcellular organs through various drug carriers for controlling drug release and absorption, so as to improve the pharmacological activity, overcome the limited solubility, low bioavailability, poor biological distribution and lack of selectivity, or to minimize the adverse effects ( Li et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Under this circumstance, researchers around the world have explored a variety of new nanocarriers and targeted modification systems to overcome these shortcomings and improve the therapeutic outcomes ( Ghaz-Jahanian et al, 2015 ; Bai et al, 2021 ; Shakeran et al, 2021 ; Dubey et al, 2022 ). Because nanotechnology provides a suitable means for the targeted and time-controlled delivery of drugs and other bioactive agents, it has been widely studied in drug delivery and has potential application prospects in cancer treatment ( Sabra et al, 2017 ; George et al, 2019 ; Ion et al, 2021 ; Maspes et al, 2021 ; Sohrabi and Packirisamy, 2021 ; Li et al, 2022 ). Drug delivery systems (DDSs) refer to the methods of delivering drugs to the targeted tissues, organs, cells or subcellular organs through various drug carriers for controlling drug release and absorption, so as to improve the pharmacological activity, overcome the limited solubility, low bioavailability, poor biological distribution and lack of selectivity, or to minimize the adverse effects ( Li et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Besides, several investigations have shown that the optimal size for efficient cellular uptake of gold NPs is 50 nm ( Jiang et al, 2008 ; Albanese and Chan, 2011 ; Huang et al, 2012 ). The results also show that internalization efficiency on human adipose-derived stem cells of spherical NPs in the range of 30–50 nm is higher than that of NPs with sizes of 15, 75, and 100 nm ( Sohrabi Kashani and Packirisamy, 2021 ).…”
Section: Functional Identification and Tools Of Npsmentioning
confidence: 91%
“…It is a treatment that can target and destroy certain types of sick tissues while retaining healthy cells. NPs with specific properties are designed for targeted therapy to transport therapeutic agents to tumor sites and release them under controlled conditions ( Sohrabi Kashani and Packirisamy, 2021 ). By securely delivering therapeutic medications to damaged areas or specific cells, these technologies may be able to overcome the constraints of previous methods and improve the therapeutic effect ( Jurj et al, 2017 ; Mu et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…They observed that these nanomaterials directly interact with actin networks after entering cells. Different parameters such as size, morphology, surface chemistry, NPs concentration, incubation time, and cell type can influence how NPs interact with cytoskeletal structures . For example, Yang and co-workers showed that the migration of prostate carcinoma cells is reduced in the presence of gold NPs, while the migration of human dermal fibroblasts (HDF) is dependent on surface charges and shape of gold NPs.…”
Section: Introductionmentioning
confidence: 99%